We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleImatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.AuthorsPrey, S.; Ezzedine, K.; Doussau, A.; Grandoulier, A.-S.; Barcat, D.; Chatelus, E.; Diot, E.; Durant, C.; Hachulla, E.; de Korwin-Krokowski, J.-D.; Kostrzewa, E.; Quemeneur, T.; Paul, C.; Schaeverbeke, T.; Seneschal, J.; Solanilla, A.; Sparsa, A.; Bouchet, S.; Lepreux, S.; Mahon, F.-X.PublicationBritish Journal of Dermatology, 2012, Vol 167, Issue 5, p1138ISSN0007-0963Publication typearticleDOI10.1111/j.1365-2133.2012.11186.x